The global subcutaneous nucleic acid therapeutics market size was valued at USD 2.88 billion in 2024 and is expected to reach USD 5.02 billion by 2032, at a CAGR of 7.20% during the forecast period. The market expansion is primarily driven by advancements in RNA-based therapies and gene-mo